The report "Europe Capnography Equipment Market by Product (Multiparameter, Standalone, Software, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User (Hospitals, ASC) – Forecast to 2031", is projected to reach USD 0.17 billion by 2031, up from USD 0.14 billion in 2026, at a CAGR of 4.0% during the forecast period.
Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Europe Capnography Equipment Market by Product (Multiparameter, Standalone, Software, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User (Hospitals, ASC) – Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-capnography-equipment-market-31481006.html
Surgical and diagnostic procedures that require anesthesia and sedation have led to an increasing number of patients being monitored for breathing by doctors using respiratory monitoring systems to ensure safety. One reason the Europe capnography equipment market is accelerating is the growing number of surgeries and diagnostic procedures. The rising prevalence of chronic respiratory and cardiovascular diseases, along with rapidly aging population trends, is significantly increasing demand for advanced monitoring solutions in intensive care units and emergency departments. Hospitals and medical facilities, as well as ambulatory care settings, are the primary focus of the market, driven by the adoption of patient safety guidelines and the adoption of clinical guidelines recommending capnography during anesthesia and sedation. In addition, continuous upgrades to capnography devices, including portable monitors, integrated multi-parameter systems, and more accurate sensors, have further expanded clinical use. The growing recognition among healthcare professionals of the benefits of early detection of respiratory conditions, coupled with expanding applications in non-intubated patients, has deeply influenced the overall market growth in Europe.
Capnography accessories and disposables accounted for the largest share by product in the Europe capnography equipment market in 2025.
By product, capnography accessories and disposables account for the largest share of the European capnography equipment market, primarily due to their frequent, routine use in healthcare facilities. Charcoal filters, nasal cannulas (or prongs), sampling lines, and adapters must be replaced regularly to ensure accurate readings and to meet the stringent infection control and hygiene standards. As a result, hospitals and clinics are a source of repeat demand for these consumables. The widespread use of capnography in operating rooms, intensive care units, and emergency departments further increases consumption of these items, which are discarded after a single use. Additionally, the use of capnography for non-intubated patients during procedural sedation and post-anesthesia recovery has led to increased demand for specialized nasal cannulas and related accessories. Hence, the recurring need for disposable products, rising procedure volumes, and stringent patient safety regulations have made accessories and disposables the top product category in the European market.
The cardiac care segment accounted for the largest share in the Europe capnography equipment market, by application, in 2025.
The cardiac care segment in the European capnography equipment market held the largest share among application segments, as cardiac patients are among those who most critically require ongoing respiratory and circulatory monitoring. Capnography is a crucial method for assessing ventilation status and, along with other parameters, helps clinicians intervene earlier if respiratory depression or hemodynamic instability develop, such as during cardiac surgeries, catheterization procedures, and interventional cardiology treatments. It is the primary monitoring technique used in cardiac intensive care units and operating rooms to monitor patients under anesthesia or mechanical ventilation, where accurate end-tidal CO2 measurement helps inform timely clinical decisions. In addition, the high incidence of cardiovascular diseases in Europe, the increasing number of cardiac interventions, and an aging population have all contributed to the rising demand for advanced monitoring solutions. Therefore, because real-time, non-invasive patient monitoring in the cardiac care segment is a necessity, this segment has become the largest application area in the European capnography equipment market.
In 2025, the UK accounted for the second-largest share of the Europe capnography equipment market.
The UK is the second-largest contributor to the European market for capnography equipment. It has a well-developed healthcare infrastructure, and the country witnesses strong adoption of advanced patient monitoring technologies. The UK consistently has high volumes of surgical procedures, emergency admissions, and critically ill patients. As a result, there is constant demand for capnography in operating theaters, intensive care units, and emergency departments. In addition, patient safety protocols emphasizing continuous monitoring of respiratory function during anesthesia and procedural sedation have become increasingly popular. Together, these factors have driven the increased use of capnography in medical practice. Moreover, the presence of top-tier hospitals, the rising investment in medical technology, and a strong focus on improving perioperative and critical care outcomes have sustained market growth. Together, these factors place the UK at the forefront of the European market for capnography equipment, holding the second position in terms of market share.
Key Market Players
The key players in the Europe capnography equipment market are Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Masimo (US), GE Healthcare (US), Becton, Dickinson and Company (US), Drägerwerk AG & Co. KGaA (Germany), Nihon Kohden Corporation (Japan), ICU Medical, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), ZOLL Medical Corporation (US), EDAN Instruments, Inc. (China), Hamilton Medical (Switzerland), Nonin (US), SCHILLER (Switzerland), and ResMed Inc. (US), among other players.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/